KENAI THERAPEUTICS
Live / Registered — Registered (as of 02 Jun 2026)
What this means for you
Registered since 02 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2032: the §8 declaration of use).
Record
- Serial number
- 98613579
- Registration number
- 8286509
- Mark type
- Word mark
- Filed
- 21 Jun 2024
- Published for opposition
- 04 Mar 2025
- Registered
- 02 Jun 2026
- Next maintenance filing
- §8 declaration of use, due by 02 Jun 2032 (grace period to 02 Dec 2032)
- Attorney of record
- April Wurster
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic preparations for neurodegenerative diseases
Owner
- Kenai Therapeutics, Inc., Cambridge, MA, US
- Kenai Therapeutics, Inc., Cambridge, MA, US
- Kenai Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 02 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 08 May 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 May 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 May 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Apr 2026 — NON-FINAL ACTION E-MAILED
- 07 Apr 2026 — SU - NON-FINAL ACTION - WRITTEN
- 07 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Oct 2025 — USE AMENDMENT FILED
- 27 Oct 2025 — TEAS STATEMENT OF USE RECEIVED